Chief Executive Officer (1) · Silo Pharma, Inc. (SILO)

Eric Weisblum

A named executive officer of Silo Pharma in every fiscal year CompBrief holds from FY2024 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$521,750

Salary $350,000Stock awards $0

FY2024: $630,051

1st of 2 named executive officers at Silo Pharma by FY2025 total.

2 named officers on file for Silo Pharma, FY2025

Eric Weisblum’s pay file — $29

  • 2 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Silo Pharma’s whole pay program stands against its peers

  • Silo Pharma’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on SILO→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed June 30, 2026 (DEF 14A).

Free

Get Eric Weisblum’s full pay file as a PDF — free

More than this page: up to 10 years of Eric’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Eric Weisblum compensation by year

Silo Pharma Summary Compensation Table · all 2 fiscal years held
In US dollars, as Silo Pharma reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024FY2025
Salary$350,000$350,000
Bonus$200,000$0
Stock awards$0$0
Option awards$0$83,782
Non-equity incentive$0$0
Pension and deferred compensation$0$0
All other$80,051$87,968
Total$630,051$521,750

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Silo Pharma, Inc. DEF 14A filed June 30, 2026, accession 0001213900-26-073367, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Silo Pharma, Inc. filed document, accession 0001213900-26-073367. Every figure is read from that document and cited to the page and table it appears in. Filed June 30, 2026.

$630K
$522K
FY24
FY25
SalaryBonusOption awardsAll other

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
Option13,333—$6.43

Per the Outstanding Equity Awards at Fiscal Year-End table in Silo Pharma, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Silo Pharma’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Eric Weisblum · this pageChief Executive Officer (1)$521,750
Daniel RyweckChief Financial Officer$101,494

The full Silo Pharma compensation record

free company brief

This page is one person within Silo Pharma's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Silo Pharma's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Eric Weisblum's compensation dossier · One-time report. No refunds.